General Information of This Drug (ID: DMA7PEW)

Drug Name
Verapamil   DMA7PEW
Synonyms
Arpamyl; Calan; Calcan; Cordilox; Dexverapamil; Dilacoran; Drosteakard; Iproveratril; Isoptimo; Isoptin; Isotopin; Vasolan; Veracim; Verapamilo; Verapamilum; Veraptin; Verexamil; Bosoptin (TN); Calan (TN); D-365; Isoptin (TN); Verapamilo [INN-Spanish]; Verapamilum [INN-Latin]; Verelan (TN); CP-16533-1; Covera-HS (TN); Verapamil (USAN/INN); Verapamil [USAN:BAN:INN]; Verapamil [USAN:INN:BAN]; Alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile; Alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile; (+-)-Verapamil; (+/-)-VERAPAMIL; (1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile; 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile; 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile; 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile; 5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile; Verapamil (Na-Ca chanel blocker)
Indication
Disease Entry ICD 11 Status REF
Angina pectoris BA40 Approved [1]
Atrial fibrillation BC81.3 Approved [1]
Classic phenylketonuria N.A. Approved [1]
Hypertension BA00-BA04 Approved [2]
Malignant essential hypertension BA00 Approved [1]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2/3 [3]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Analgesics
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

20 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Dihydroergotamine + Verapamil DC3LFRE Dihydroergotamine DD2 (Cell Line: DD2) [4]
JTC-801 + Verapamil DCX89UH JTC-801 DD2 (Cell Line: DD2) [4]
NITD609 + Verapamil DC8T65B NITD609 DD2 (Cell Line: DD2) [4]
NITD609 + Verapamil DCVVKDA NITD609 Hepatoblastoma (Cell Line: HB3) [5]
Omacetaxine mepesuccinate + Verapamil DCUTDR3 Omacetaxine mepesuccinate Hepatoblastoma (Cell Line: HB3) [5]
Proguanil + Verapamil DCFVO5D Proguanil DD2 (Cell Line: DD2) [4]
SB 228357 + Verapamil DCRIXDN SB 228357 DD2 (Cell Line: DD2) [4]
Sorafenib + Verapamil DCQJL04 Sorafenib DD2 (Cell Line: DD2) [4]
Verapamil + OZ277 DC134AR OZ277 DD2 (Cell Line: DD2) [5]
Verapamil + Lumefantrine DC8O7LO Lumefantrine DD2 (Cell Line: DD2) [5]
Verapamil + Diltiazem DCJI66A Diltiazem DD2 (Cell Line: DD2) [5]
Verapamil + SB 228357 DCA3C5U SB 228357 DD2 (Cell Line: DD2) [5]
Verapamil + SB 228357 DC53SQ6 SB 228357 Hepatoblastoma (Cell Line: HB3) [5]
Verapamil + Epothilone B DCC92QV Epothilone B Hepatoblastoma (Cell Line: HB3) [5]
Verapamil + Artemisinin DCUQIHX Artemisinin DD2 (Cell Line: DD2) [5]
Verapamil + MK-4815 DCERZAA MK-4815 DD2 (Cell Line: DD2) [5]
Verapamil + Mefloquine DCVIJ4O Mefloquine DD2 (Cell Line: DD2) [5]
Verapamil + Nitisinone DC2PNGZ Nitisinone DD2 (Cell Line: DD2) [5]
Verapamil + Vorinostat DCCE0KZ Vorinostat DD2 (Cell Line: DD2) [5]
Verapamil + Atovaquone DCK9CIM Atovaquone DD2 (Cell Line: DD2) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 20 DrugCom(s)
4 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Fostamatinib + Verapamil DCVQ9JN Fostamatinib Drug Drug Interactions [6]
Verapamil + Hydroxyurea DCK37TP Hydroxyurea Cancer [7]
Verapamil + Canagliflozin DCTQSQP Canagliflozin Type 2 Diabetes Mellitus [8]
Verapamil + Quinidine DCW8L6S Quinidine Short-coupled Idiopathic Ventricular Fibrillation [9]
------------------------------------------------------------------------------------

References

1 Verapamil FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2406).
3 ClinicalTrials.gov (NCT04351763) Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms. U.S. National Institutes of Health.
4 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
6 ClinicalTrials.gov (NCT01197781) Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers
7 ClinicalTrials.gov (NCT00706810) Combination of Hydroxyurea and Verapamil for Refractory Meningiomas
8 ClinicalTrials.gov (NCT03296800) Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
9 ClinicalTrials.gov (NCT05593757) Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular Fibrillation